Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice

被引:145
|
作者
Perluigi, M
Poon, HF
Maragos, W
Pierce, WM
Klein, JB
Calabrese, V
Cini, C
De Marco, C
Butterfield, DA [1 ]
机构
[1] Univ Kentucky, Ctr Membrane Sci, Dept Chem, Lexington, KY 40506 USA
[2] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy
[3] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
[4] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[5] Univ Louisville, Sch Med, Kidney Dis Program, Louisville, KY 40292 USA
[6] Univ Louisville, Sch Med, Core Proteom Lab, Louisville, KY 40292 USA
[7] Univ Louisville, Sch Med, Dept Pharmacol, Louisville, KY 40292 USA
[8] Vet Affairs Med Ctr, Louisville, KY 40292 USA
[9] Univ Catania, Dept Chem, Biochem Sect, I-95100 Catania, Italy
[10] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
关键词
D O I
10.1074/mcp.M500090-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Huntington disease (HD) is a hereditary neurodegenerative disorder characterized by motor, psychiatric, and cognitive symptoms. The genetic defect responsible for the onset of the disease, expansion of CAG repeats in exon 1 of the gene that codes for huntingtin on chromosome 4, has been unambiguously identified. On the other hand, the mechanisms by which the mutation causes the disease are not completely understood yet. However, defects in energy metabolism of affected cells may cause oxidative damage, which has been proposed as one of the underlying molecular mechanisms that participate in the etiology of the disease. In our effort to investigate the extent of oxidative damage occurring at the protein level, we used a parallel proteomic approach to identify proteins potentially involved in processes upstream or downstream of the disease-causing huntingtin in a well established HD mouse model (R6/2 transgenic mice). We have demonstrated that the expression levels of dihydrolipoamide S-succinyltransferase and aspartate aminotransferase increase consistently over the course of disease (10-week-old mice). In contrast, pyruvate dehydrogenase expression levels were found to be decreased in 10-week-old HD transgenic mice compared with young (4-week-old) mice. Our experimental approach also led to the identification of oxidatively modified proteins. Six proteins were found to be significantly oxidized in old R6/2 transgenic mice compared with either young transgenic mice or non-transgenic mice. These proteins are alpha-enolase, gamma-enolase (neuron-specific enolase), aconitase, the voltage-dependent anion channel 1, heat shock protein 90, and creatine kinase. Because oxidative damage has proved to play an important role in the pathogenesis and the progression of Huntington disease, our results for the first time identify specific oxidatively modified proteins that potentially contribute to the pathogenesis of Huntington disease.
引用
收藏
页码:1849 / 1861
页数:13
相关论文
共 50 条
  • [41] Hair dysmorphology in the R6/1 and R6/2 mouse models of Huntington's disease
    Pierzynowska, Karolina
    Podlacha, Magdalena
    Luszczek, Dorota
    Rintz, Estera
    Gaffke, Lidia
    Szczudlo, Zuzanna
    Tomczyk, Marta
    Smolenski, Ryszard T.
    Wegrzyn, Grzegorz
    GENE, 2021, 765
  • [42] Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients
    Sathasivam, K
    Woodman, B
    Mahal, A
    Bertaux, F
    Wanker, EE
    Shima, DT
    Bates, GP
    HUMAN MOLECULAR GENETICS, 2001, 10 (21) : 2425 - 2435
  • [43] Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease
    van der Borght, Karin
    Brundin, Patrik
    EXPERIMENTAL NEUROLOGY, 2007, 204 (01) : 473 - 478
  • [44] Tolerance to oxidative stress in the heart as a hormetic response to aldehydes: A proteomic and metabolomic analysis of ALDH2*2 transgenic mice
    Sano, Motoaki
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2008, 32 (06) : 285A - 285A
  • [45] Proteomic analysis reveals that normal retinal protein expression is suppressed in transgenic mice expressing Leukemia inhibitor factor.
    Ash, JD
    Wiechmann, AF
    Kurono, S
    Matsumoto, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S506 - S506
  • [46] ANALYSIS OF MILK PROTEIN GENE-EXPRESSION IN TRANSGENIC MICE
    ROSEN, JM
    BAYNA, E
    LEE, KF
    MOLECULAR BIOLOGY & MEDICINE, 1989, 6 (06) : 501 - 509
  • [47] Hyperkinetic and rigid gait in R6/2 mice, a model of Huntington's disease
    Hampton, T. G.
    Kale, A.
    McCue, S.
    Amende, I.
    MOVEMENT DISORDERS, 2008, 23 (01) : S185 - S185
  • [48] Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice
    Johnson, Michael A.
    Villanueva, Melissa
    Haynes, Christy L.
    Seipel, Andrew T.
    Buhler, Leah A.
    Wightman, R. Mark
    JOURNAL OF NEUROCHEMISTRY, 2007, 103 (05) : 2102 - 2110
  • [49] Light and electron microscopic characterization of the evolution of cellular pathology in the R6/1 Huntington's disease transgenic mice
    Bayram-Weston, Zubeyde
    Jones, Lesley
    Dunnett, Stephen B.
    Brooks, Simon P.
    BRAIN RESEARCH BULLETIN, 2012, 88 (2-3) : 104 - 112
  • [50] Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice
    Poon, H. Fai
    Vaishnav, Radhika A.
    Getchell, Thomas V.
    Getchell, Marilyn L.
    Butterfield, D. Allan
    NEUROBIOLOGY OF AGING, 2006, 27 (07) : 1010 - 1019